Board composition

Doug Baker currently serves as executive director of strategic partnerships at Labcorp. In this capacity, Doug works with leading pharma clients to assure delivery excellence and innovation across the Labcorp enterprise. Doug has nearly 30 years of experience in the clinical trial arena, as well as a background in hospital-based clinical microbiology.

Doug and his wife Christine reside in Brownsburg where they raised their four now-adult children. In his spare time, Doug enjoys writing, cooking, and gardening.

Doug Baker is an Indiana native and will always be a farm boy at heart. He is a graduate of Indiana University with a BS in Microbiology and a second BS in Psychology.

Mike Bolinder, senior vice president, external engagement, and chief innovation officer, has served in the life sciences sector for 20 years, most recently as CEO and executive director of Acacia Pharma Group plc, a publicly listed group of companies with headquarters in both Indianapolis, Indiana, and Cambridge, UK. Prior to Acacia, he served as head of marketing and commercial strategy for the hospital division of Mallinckrodt Pharmaceuticals, following their acquisition of Cadence Pharmaceuticals. Previously, he worked at Eli Lilly and Company in various commercial roles of increasing responsibility.

Diana Caldwell is co-founder, president and CEO of Amplified Sciences, an in vitro diagnostics start-up company dedicated to the early detection of devastating disease with a lead assay in development for pancreatic cancer. She is an accomplished and recognized life science entrepreneur with over 25 years of experience in both large corporate and small entrepreneurial environments. Throughout her career, she has successfully driven organizational growth, developed and implemented strategic business plans, and directed successful teams. She is a serial life science entrepreneur dedicated to the acceleration of innovations improving patients’ lives.

Prior to taking helm as CEO of Amplified Sciences in June of 2019, Diana served as an entrepreneur in residence at the Purdue Foundry. Diana provided guidance to students, faculty, and alumni innovators to move their start-up ideas to commercially viable companies.

Early in her career, she worked for Eli Lilly for over 15 years in a variety of general management leadership roles in product management, marketing, finance, sales, and operations. Diana founded Pensar Ideas in 2009. Pensar Ideas is a business consultancy practice focused on business planning and strategy, fundraising, business operations and product development support, commercialization strategy, and sales and marketing support for life science companies.

In 2010, Diana co-founded Pearl Pathways, where she led the company as president and CEO and oversaw all business operations, business development, legal, HR, and financial functions. Pearl Pathways is a life science product development consulting company focused on expediting regulatory pathways, building and enhancing quality management systems, delivering AAHRPP accredited IRB clinical research review services, and executing clinical trials through a niche CRO offering. Under her leadership she was able to scale the company to a multimillion-dollar company with fifteen employees and dozens of consultant partners. In 2018, she sold her interest in Pearl Pathways to pursue the start-up of another life science product company. Diana also lends her talents to several community organizations and not-for-profits including IHIF board of directors, IU Kelley School's Life Sciences Industry Advisory Board, The ARC of Indiana Foundation Board, and Senator Lugar’s Fund.

Courtney Condon is a vice president of sales with Deloitte Consulting’s Healthcare Provider practice. In this role, Courtney articulates Deloitte Consulting’s services and solutions to healthcare provider executive leadership teams as they contemplate how to plan for, select, implement, and optimize applications and technologies that help hospitals and healthcare systems improve productivity, safety, financial performance, and clinical outcomes.

Courtney has 28 years of information technology experience. For the past 20 years, he has focused solely on information technology sales and sales leadership in the healthcare provider setting. Courtney began his career in 1997 at Oracle Corporation. He has held sales leadership positions at maxIT Healthcare, Leidos Health, Nordic Consulting, and Deloitte Consulting. At Deloitte Consulting, Courtney specializes in articulating the benefits of implementing and optimizing major application platforms, including EMR, ERP, and ITSM. He also has expertise in application and infrastructure outsourcing as well as cloud strategy and migration.

Courtney is a proud graduate of Indiana University Bloomington. He was born and raised in Indianapolis. Courtney, his wife, and two teenage kids call Indianapolis home. Courtney is a big fan of the Los Angeles Dodgers, Indianapolis Colts, and Indiana University Football. He also frequently attends the Indianapolis 500 and the Indianapolis Symphony Orchestra.

Kirk Bailey is an accomplished engineering leader with over 32 years of experience in the MedTech industry. A 1992 graduate of Rose-Hulman Institute of Technology with a degree in Mechanical Engineering, Kirk has dedicated his career to advancing musculoskeletal health through innovation and leadership at Zimmer Biomet.

Throughout his tenure, he has held a variety of roles, progressing from Design Engineer to Chief Technology Officer. His expertise spans research and development, quality remediation, and manufacturing. Kirk has been instrumental in developing cutting-edge medical technologies, holding multiple patents in spine, hip, trauma, and enabling technologies.

Among his notable achievements, Kirk played a key role in growing a division of Biomet from $90 million to $425 million, leading a PLM system implementation, and overseeing engineering services post-Zimmer Biomet's 2015 merger. From 2016 to 2022, he was a core leader in a major quality remediation effort, further solidifying Zimmer Biomet’s commitment to excellence. As CTO, he has driven advancements in research and development, enhancing the company’s innovation pipeline and vitality index.

Passionate about innovation and improving patient outcomes, Kirk continues to lead embodying Zimmer Biomet’s mission to "Alleviate pain and improve the quality of life for people around the world."

John Hauser is the vice president of operations for Boston Scientific’s Spencer, Indiana, manufacturing facility where he leads the team of 1500+ individuals who support all aspects of operations at the Spencer site. In this role, he is the senior leader responsible for the site’s strategic direction, P&L performance, and serves as Management with Executive Responsibility for Quality System Operations. 

John joined Boston Scientific in 2007 as a manufacturing engineering manager in Arden Hills, Minnesota, supporting the Cardiac Rhythm Management division before relocating to Dorado, Puerto Rico, in 2012 as the site’s engineering director. In 2016, he went on to support an acquisition integration for the Neuromodulation division in California before joining Boston Scientific’s Process Development (PD) leadership team in 2017.

As a director and then vice president, John led global teams supporting Endoscopy and Urology divisions in Massachusetts, Indiana, Costa Rica, India, and Malaysia. He and his family relocated to Indiana when he joined the Spencer team in October 2020. 

As an advocate for DEI, John sponsors the Spencer VETS employee resource group (ERG), an affinity group for veterans and their allies. Throughout his career he has been a champion for women’s advancement as sponsor for Society of Women in Engineering (SWE); EXCELerate, a Boston Scientific program that promotes women’s professional growth; and Men Advocating for Real Change discussion groups. He has also been active in various Boston Scientific ERGs including the Young Professionals Network and HOLA, the internal affinity group for LatinX colleagues and their allies. John also actively mentors colleagues and emerging talent throughout the global Boston Scientific network. In 2023, John joined the board of directors for the Greater Bloomington Chamber of Commerce and actively supports the local business community and charitable organizations.

Prior to joining Boston Scientific, John spent eight years in the US Navy’s submarine force serving as a nuclear engineering officer on submarines in Virginia and Hawaii and spent two years as officer-in-charge of the Navy ROTC unit at Duke University. 

Outside of work, John is an avid golfer and enjoys travelling through the Caribbean with his wife Michelle. They enjoy finding incredible food in the cities they visit and frequently attend live music and comedy shows. They share their home with their rescue golden retriever (Hank) and are active volunteers with golden retriever rescue organizations in Indiana and Minnesota.

Jennifer Kowalski is the vice president of the Public Policy Institute at Elevance Health, one of the nation’s leading health companies.

The Elevance Health Public Policy Institute works to advance meaningful change in the healthcare system through publication of policy-relevant data analysis, timely research, and insights from Elevance Health’s innovative programs. In her role as head of the Public Policy Institute, Jenn directs policy research and data analysis, convenes and connects with experts, supports external research, and oversees the production of papers, issue briefs, and other materials that contribute thought leadership to the health policy debate.  

Prior to joining Elevance Health, Jenn was vice president at Avalere Health, a Washington, D.C.-based health policy consulting firm, where she spent more than nine years. At Avalere, Jenn advised managed care and life sciences companies on policy and strategy related to health insurance reform and the Affordable Care Act, Medicare Advantage and Part D, and Medicaid. As co-director of the Health Reform Practice, she also led the strategic direction and day-to-day management of a practice of 30 professionals.

Previously, Jenn was a consultant at The Lewin Group, where she focused on quantitative analysis and program evaluation of mental health and substance use treatment initiatives. Jenn holds a Master of Science in Health Policy and Management from the Harvard University School of Public Health and a Bachelor of Arts in Community Health from Brown University. 

Matt Manley has 25 years of experience working in the in vitro diagnostic industry in customer-engaging roles in strategy, marketing, sales, and training. Over the past 15+ years with Roche, Matt has worked in solution portfolios covering clinical chemistry, immunoassay, molecular PCR-point of care, coagulation monitoring, hospital glucose POC and IT. During the global coronavirus pandemic, Matt helped lead Roche’s response, which delivered over 150 million tests at the point of care to the US market. Most recently, Matt has assumed a role within Roche as vice president of digital healthcare solutions business in the US. Roche’s ambition is to create value for patients, for healthcare systems, and ultimately, for society through advances in digital healthcare with a focus on early disease identification and detection.

Stephanie leads a team of experienced marketing and learning and development professionals to advance the practice of marketing at Eli Lilly & Company. Stephanie’s team leads talent development of marketers, sets standards and frameworks for launch excellence and brand leadership, consults with teams on critical strategic marketing decisions, and upskills the worldwide marketing organization for the future, including a focus on data-driven decision making.

Since joining Lilly in 2011, Stephanie has held multiple brand marketing roles with a heavy focus in consumer marketing, including leadership of a migraine launch. Her team’s work has resulted in building multiple new capabilities for the organization.

Prior to Lilly, she worked in consumer-packaged goods, creating product innovation and communication campaigns at Unilever and PepsiCo for brands such as Axe, Degree for Men, Dove, and Quaker. Throughout her career, she has focused on uncovering and understanding deep, emotional insights from consumers, translating these insights into meaningful strategies and building resonant, powerhouse brands.

For her contributions she has earned multiple recognitions including: Brand Innovators 40 under 40; MM&M award for best use of Social Media, Gartner Digital IQ “Genius” Award, and Top 25 DTC Marketer Award from DTC National. Stephanie holds an MBA from Northwestern’s Kellogg School of Management and a Bachelor of Science degree from Indiana University’s Kelley School of Business.

Dan Peterson is vice president of industry and government affairs for Cook Group Incorporated, based in Bloomington, Indiana. Since joining Cook in 1989, Dan has held a variety of leadership roles in the areas of operations, finance, accounting, and human resources. Dan’s current responsibilities involve industry, government, and external affairs. His primary areas of focus center on policies and programs in healthcare delivery as well as education, economic and workforce development.

Dan earned a BS in Biology from Indiana University in 1984 and an MBA in Finance, also from Indiana University, in 1989.

Dan serves on the board of directors for a variety of organizations throughout Indiana, including BioCrossroads; Indiana Health Industry Forum; the Regional Opportunities Initiative, Inc.; and the Bloomington Economic Development Corporation. Dan also serves as chairman of the South Central Regional Board of Indiana University Health and is one of the founding board members for the Indiana Bioscience Research Institute. Dan serves as a commission member of the Indiana Commission for Higher Education and is the immediate past chairman.

Since 1963, Cook Group companies are combining medical devices, biologic materials, and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. Cook Group companies employ more than 12,000 people globally with operations in North America, Europe, and Asia-Pacific. Today, Cook manufactures more than 16,000 products that serve more than 40 medical specialties in 135 countries.

Lesley Jolivette serves as vice president of Patient Experience and chief of staff for System and Regional Operations at Indiana University Health. In her role, Lesley leads the strategic vision and execution of IU Health’s system-wide patient experience program ensuring every interaction reflects compassionate, equitable, and patient-centered care. As chief of staff, she supports the executive vice president chief nurse executive for IU Health and the senior vice president of System Regional Operations. Lesley joined IU Health in 2008 and has served in a variety of operational and leadership roles.

She earned her master's in health administration and Bachelor of Science in Health Administration from Indiana University and a certificate in business from the Kelley School of Business. Lesley is a fellow in the American College of Healthcare Executives and is a certified Lean Six Sigma black belt.

In addition to serving on the Kelley Life Sciences Advisory Board, Lesley serves on the IU Women’s Philanthropy Leadership Council and as adjunct faculty in the Master of Science in Healthcare Management program at IU.

Taryn Stone is a partner and chair of the Firm's Health Care Group, concentrating her practice on various aspects of health law. Taryn represents various providers and suppliers of healthcare services including hospitals, physicians, and medical device manufacturers on transactional and regulatory issues. Her practice includes counseling clients on matters involving Medicare conditions of participation, Medicare and Medicaid billing and reimbursement issues, the Stark and Anti-Kickback laws and similar state laws, the False Claims Act, HIPAA and other state privacy and security laws, and state licensure laws and regulations. She is also a member of the Firm's Internet of Things (IoT) Group.

Taryn has represented many healthcare providers on a wide variety of matters, including structuring complex healthcare arrangements under the Stark and Anti-Kickback laws; the formation, operation and sale of physician group practices; negotiating contracts; mergers and acquisitions; and employment matters and other business arrangements between providers, manufacturers and other entities. Previously, Taryn served as in-house counsel for a large, publicly traded home health and hospice company. Taryn also worked as a healthcare consultant for a national consulting firm helping clients develop and implement co-management arrangements.

Taryn graduated from Washington University in St. Louis in 2002 with a Bachelor of Arts degree. While at Wash U, she was captain of the Washington University Women's Swimming & Diving team. She received her juris doctorate, magna cum laude, from Indiana University School of Law-Indianapolis in 2005. While in law school, she was an articles editor for the Indiana Law Review and a volunteer in the school's pro bono group.

Taryn's memberships include American Health Lawyers Association Community Involvement Stanley K. Lacy Executive Leadership Series; Class XLII Women's Fund of Central Indiana; OPTIONS Class 16 pro-bono volunteer; Neighborhood Christian Legal Clinic Board Secretary and member of the executive and finance committees; Choices, Inc. Board Member; Intercollegiate YMCA Advisory Board Member; First Book of Greater Indianapolis Law Student Mentor; Leadership Council on Legal Diversity Past Chair; Indianapolis Alumni; and Parents Admission Program for Washington University in St. Louis Co-Team Leader; Women's Build for Habitat for Humanity; 2018 WISH (Women Inspiring Strength and Hope) Class for Make-A-Wish Ohio, Kentucky, and Indiana program; member of the Health Law Society, and member of the Dean's Tutorial Society. Taryn is admitted to practice law in the states of Indiana and North Carolina.

Tracey Ward brings 25 years of global leadership expertise in product development, regulatory affairs, strategic initiatives, and operational excellence, including a two year assignment in Basel, Switzerland. As Elanco's Executive Director of Enterprise Data Analytics, she champions the advancement of data-driven decision-making and AI readiness, while driving productivity through process efficiency.

Throughout her career, Tracey has held pivotal roles in Global Product Development, CMC, Six Sigma, Regulatory Affairs, and Pharmacovigilance. She had the unique opportunity to lead the global Pharmaceutical and Vaccine Science and Technology team from Basel, Switzerland, impacting key Elanco brands such as Seresto®, Trifexis®, Comfortis®, Micotil®, and Galliprant®. Tracey's academic background includes a Master of Science in Analytical Chemistry from the University of Georgia and a Bachelor of Science from Piedmont University. She has furthered her leadership capabilities with executive courses at Harvard Business School and certifications from Eli Lilly & Company, including a Lean Six Sigma Black Belt. She participated in Eli Lilly’s comprehensive leadership programs, enhancing her strategic skills.

For her contributions she has earned recognition at Elanco and in the industry. At Elanco, these include several Team of the Year Awards, two Quality Advocate Awards, a Pinnacle Partner award, being selected to represent Elanco in Lilly’s TEDx event and nominations for Coaching, Mentoring and Allyship in Elanco’s Women’s Network. Externally, she has been recognized with a nomination for the “Feather in Her Cap” Award that recognizes women with a track record of achievement and mentorship in the Animal Health Industry.

Beyond her professional pursuits, Tracey serves on advisory boards, such as the IU Kelley School of Business and Gleaners Food Bank. Her passion for baking with her two children with their dog at her feet reflects her belief in Elanco's mission of food and companionship enriching lives.

Michael has 21 years of experience in the pharmaceutical industry, all with AbbVie (and Abbott prior to that).  He leads the UnitedHealth Group (UHG) Corporate Account Team in US Market Access ensuring successful negotiations to maintain or advance product access across the AbbVie portfolio aligned with brand strategy and financial objectives.  Michael works to strengthen the strategic relationship between AbbVie and UHG enhancing partnerships with customer stakeholders across multiple arms of the enterprise, and he works closely with internal cross-functional stakeholders to develop strategy and provide customer insights integrating rapid changes in the landscape and changes in payer approaches directly into AbbVie’s efforts.

Michael spent the first half of his career in Finance, beginning in Abbott’s Finance Development Program and then progressing through multiple roles across the organization.  Upon moving into US Market Access in 2016, Michael held multiple leadership roles prior to his current role that include leading the Immunology portfolio strategy and contracting team supporting National Payer customer negotiations, as well as leading Payer Strategy for the Dermatology therapeutic area through two successful indication launches for SKYRIZI and RINVOQ.

Michael holds a Bachelor of Science in Finance from the IU Kelley School of Business.